Leonid Barski, Tamar Eshkoli, Evgenia Brandstaetter, Alan Jotkowitz. Eur J Intern Med 2019
Times Cited: 27
Times Cited: 27
Times Cited
Times Co-cited
Similarity
Hyperglycemic crises in adult patients with diabetes.
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
48
29
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
29
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.
Julio Rosenstock, Ele Ferrannini. Diabetes Care 2015
Julio Rosenstock, Ele Ferrannini. Diabetes Care 2015
25
Euglycemic Diabetic Ketoacidosis: A Review.
Anar Modi, Abhinav Agrawal, Farah Morgan. Curr Diabetes Rev 2017
Anar Modi, Abhinav Agrawal, Farah Morgan. Curr Diabetes Rev 2017
25
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
22
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
22
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors.
Wataru Ogawa, Kazuhiko Sakaguchi. J Diabetes Investig 2016
Wataru Ogawa, Kazuhiko Sakaguchi. J Diabetes Investig 2016
22
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
18
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
18
SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
18
SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications.
Emily J Meyer, Genevieve Gabb, David Jesudason. Diabetes Care 2018
Emily J Meyer, Genevieve Gabb, David Jesudason. Diabetes Care 2018
18
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
18
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
14
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.
Joseph I Wolfsdorf, Nicole Glaser, Michael Agus, Maria Fritsch, Ragnar Hanas, Arleta Rewers, Mark A Sperling, Ethel Codner. Pediatr Diabetes 2018
Joseph I Wolfsdorf, Nicole Glaser, Michael Agus, Maria Fritsch, Ragnar Hanas, Arleta Rewers, Mark A Sperling, Ethel Codner. Pediatr Diabetes 2018
14
Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.
Daisuke Yabe, Masahiro Iwasaki, Hitoshi Kuwata, Takuya Haraguchi, Yoshiyuki Hamamoto, Takeshi Kurose, Kiminobu Sumita, Hitoshi Yamazato, Shigeto Kanada, Yutaka Seino. Diabetes Obes Metab 2017
Daisuke Yabe, Masahiro Iwasaki, Hitoshi Kuwata, Takuya Haraguchi, Yoshiyuki Hamamoto, Takeshi Kurose, Kiminobu Sumita, Hitoshi Yamazato, Shigeto Kanada, Yutaka Seino. Diabetes Obes Metab 2017
14
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
14
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
14
Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.
Pablo Lucero, Sebastián Chapela. Case Rep Crit Care 2018
Pablo Lucero, Sebastián Chapela. Case Rep Crit Care 2018
26
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
Guillermo Umpierrez, Mary Korytkowski. Nat Rev Endocrinol 2016
Guillermo Umpierrez, Mary Korytkowski. Nat Rev Endocrinol 2016
11
Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014.
Stephen R Benoit, Yan Zhang, Linda S Geiss, Edward W Gregg, Ann Albright. MMWR Morb Mortal Wkly Rep 2018
Stephen R Benoit, Yan Zhang, Linda S Geiss, Edward W Gregg, Ann Albright. MMWR Morb Mortal Wkly Rep 2018
11
Incidence of Diabetic Ketoacidosis of New-Onset Type 1 Diabetes in Children and Adolescents in Different Countries Correlates with Human Development Index (HDI): An Updated Systematic Review, Meta-Analysis, and Meta-Regression.
Johann Große, Henriette Hornstein, Ulf Manuwald, Joachim Kugler, Ingmar Glauche, Ulrike Rothe. Horm Metab Res 2018
Johann Große, Henriette Hornstein, Ulf Manuwald, Joachim Kugler, Ingmar Glauche, Ulrike Rothe. Horm Metab Res 2018
12
Euglycaemic diabetic ketoacidosis: does it exist?
D Jenkins, C F Close, A J Krentz, M Nattrass, A D Wright. Acta Diabetol 1993
D Jenkins, C F Close, A J Krentz, M Nattrass, A D Wright. Acta Diabetol 1993
11
Risk of death following admission to a UK hospital with diabetic ketoacidosis.
Fraser W Gibb, Wei Leng Teoh, Joanne Graham, K Ann Lockman. Diabetologia 2016
Fraser W Gibb, Wei Leng Teoh, Joanne Graham, K Ann Lockman. Diabetologia 2016
11
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management.
Ebenezer A Nyenwe, Abbas E Kitabchi. Metabolism 2016
Ebenezer A Nyenwe, Abbas E Kitabchi. Metabolism 2016
11
Diabetic ketoacidosis: risk factors and management strategies.
Guillermo E Umpierrez, Abbas E Kitabchi. Treat Endocrinol 2003
Guillermo E Umpierrez, Abbas E Kitabchi. Treat Endocrinol 2003
11
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini. Diabetes Obes Metab 2018
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini. Diabetes Obes Metab 2018
11
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
11
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System.
Gian Paolo Fadini, Benedetta Maria Bonora, Angelo Avogaro. Diabetologia 2017
Gian Paolo Fadini, Benedetta Maria Bonora, Angelo Avogaro. Diabetologia 2017
11
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.
. Diabetes Care 2019
. Diabetes Care 2019
11
Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication.
Asma Abu-Abed Abdin, Muhammad Hamza, Muhammad S Khan, Awab Ahmed. Case Rep Crit Care 2016
Asma Abu-Abed Abdin, Muhammad Hamza, Muhammad S Khan, Awab Ahmed. Case Rep Crit Care 2016
33
Starvation-induced true diabetic euglycemic ketoacidosis in severe depression.
Franklin Joseph, Lydia Anderson, Niru Goenka, Jiten Vora. J Gen Intern Med 2009
Franklin Joseph, Lydia Anderson, Niru Goenka, Jiten Vora. J Gen Intern Med 2009
11
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects.
Anastasios Tentolouris, Panayotis Vlachakis, Evangelia Tzeravini, Ioanna Eleftheriadou, Nikolaos Tentolouris. Int J Environ Res Public Health 2019
Anastasios Tentolouris, Panayotis Vlachakis, Evangelia Tzeravini, Ioanna Eleftheriadou, Nikolaos Tentolouris. Int J Environ Res Public Health 2019
11
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
11
Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.
D A Milder, T Y Milder, P C A Kam. Anaesthesia 2018
D A Milder, T Y Milder, P C A Kam. Anaesthesia 2018
15
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta. BMJ 2019
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta. BMJ 2019
7
Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31,330 young patients with type 1 diabetes.
Beate Karges, Joachim Rosenbauer, Paul-Martin Holterhus, Peter Beyer, Horst Seithe, Christian Vogel, Andreas Böckmann, Dirk Peters, Silvia Müther, Andreas Neu,[...]. Eur J Endocrinol 2015
Beate Karges, Joachim Rosenbauer, Paul-Martin Holterhus, Peter Beyer, Horst Seithe, Christian Vogel, Andreas Böckmann, Dirk Peters, Silvia Müther, Andreas Neu,[...]. Eur J Endocrinol 2015
7
CAUSES AND PREDICTORS FOR 30-DAY RE-ADMISSIONS IN ADULT PATIENTS WITH DIABETIC KETOACIDOSIS IN THE UNITED STATES: A NATIONWIDE ANALYSIS, 2010-2014.
Carolina R Hurtado, Alejandro Lemor, Franco Vallejo, Katherine Lopez, Rodrigo Garcia, Joseph Mathew, Rodolfo J Galindo. Endocr Pract 2019
Carolina R Hurtado, Alejandro Lemor, Franco Vallejo, Katherine Lopez, Rodrigo Garcia, Joseph Mathew, Rodolfo J Galindo. Endocr Pract 2019
28
An Evaluation of Recurrent Diabetic Ketoacidosis, Fragmentation of Care, and Mortality Across Chicago, Illinois.
James A Mays, Kathryn L Jackson, Teresa A Derby, Jess J Behrens, Satyender Goel, Mark E Molitch, Abel N Kho, Amisha Wallia. Diabetes Care 2016
James A Mays, Kathryn L Jackson, Teresa A Derby, Jess J Behrens, Satyender Goel, Mark E Molitch, Abel N Kho, Amisha Wallia. Diabetes Care 2016
7
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
7
National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014.
K K Dhatariya, I Nunney, K Higgins, M J Sampson, G Iceton. Diabet Med 2016
K K Dhatariya, I Nunney, K Higgins, M J Sampson, G Iceton. Diabet Med 2016
7
Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis.
Dimpi Desai, Dhruv Mehta, Priyanka Mathias, Gopal Menon, Ulrich K Schubart. Diabetes Care 2018
Dimpi Desai, Dhruv Mehta, Priyanka Mathias, Gopal Menon, Ulrich K Schubart. Diabetes Care 2018
7
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
7
Ketoacidosis occurs in both Type 1 and Type 2 diabetes--a population-based study from Northern Sweden.
Z H Wang, E Kihl-Selstam, J W Eriksson. Diabet Med 2008
Z H Wang, E Kihl-Selstam, J W Eriksson. Diabet Med 2008
7
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C Bain, Serge Jabbour, Niki Arya,[...]. Diabetes Care 2018
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C Bain, Serge Jabbour, Niki Arya,[...]. Diabetes Care 2018
7
The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use.
K K Dhatariya, C Skedgel, R Fordham. Diabet Med 2017
K K Dhatariya, C Skedgel, R Fordham. Diabet Med 2017
11
Guidelines for management of diabetic ketoacidosis: time to revise?
Ketan K Dhatariya, Guillermo E Umpierrez. Lancet Diabetes Endocrinol 2017
Ketan K Dhatariya, Guillermo E Umpierrez. Lancet Diabetes Endocrinol 2017
13
Risk Factors for Recurrent Diabetic Ketoacidosis in Adults With Type 1 Diabetes.
Sophie Del Degan, Frédérique Dubé, Claudia Gagnon, Geneviève Boulet. Can J Diabetes 2019
Sophie Del Degan, Frédérique Dubé, Claudia Gagnon, Geneviève Boulet. Can J Diabetes 2019
25
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
7
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.